f your goal is to galvanize media attention around bread-and-butter issues, whining to Jake Tapper seems like a less effective tactic than, say, taking interesting stances on bread-and-butter issues. And yet, as
Vox’s Matt Yglesias notes, it has been House moderates — not Ilhan Omar, Ayanna Pressley, Rashida Tlaib, or AOC — who have prevented House Democrats from advancing several of their most compelling messaging bills. Nancy Pelosi’s caucus finally passed a $15 federal minimum wage Thursday. But Pelosi had promised to pass that (
popular) policy within
100 hours after assuming the speakership. Instead, it has taken seven months for her to grind down moderate opposition.
Meanwhile, centrist Democrats have
blocked their party from
passing a bill that would allow Medicare to negotiate drug prices, a measure that would effectively transfer large sums of money out of Big Pharma’s profit margins and into seniors’ pockets. This a winning issue in every district in the country (at least, if you value the approval of voters more than lobbyists). A recent
Kaiser Family Foundation poll found that 86 percent of Americans approve of Medicare negotiating lower drug prices. There is a reason that Donald Trump
pretended to support such a policy through the bulk of his presidential campaign, and is now
desperately searching for more industry-friendly means of pushing down the cost of pharmaceuticals. The GOP cannot compete at the national level
without winning an outsize share of older voters. And older voters cannot stomach the rising cost of their pills. This gives Democrats a golden opportunity to expand their coalition by gaining the upper hand on a high-salience issue: As the party that’s less allergic to price controls, they’re well-positioned to give a right-leaning constituency something it desperately wants, but cannot get from the GOP.
But moderate Democrats
aren’t letting them.